• New Leaf Ventures (NLV) has signed a letter of intent to acquire High Profile Holdings Corp.
  • High Profile is a retail-focused private British Columbia cannabis company that offers premium cultivated products
  • High Profile brings pre-existing relationships with both seasoned retailers and government regulatory bodies. These strategic partnerships offer product listings in retail chains across Canada
  • Shares in New Leaf Ventures (NLV) opened trading at C$0.27

New Leaf Ventures (NLV) has signed a letter of intent to acquire High Profile Holdings Corp.

High Profile is a retail-focused private British Columbia cannabis company that offers premium cultivated products.

High Profile brings pre-existing relationships with both seasoned retailers and government regulatory bodies. These strategic partnerships offer product listings in retail chains across Canada.

High Profile Holdings’ President, Dean Medwid, said that this partnership will see High Profile’s genetic library enter the legal market in Canada.

New Leaf’s President and CEO, Mike Stier, added that the team behind High Profile has a history of operational success.

“We believe that the proposed acquisition of High Profile not only opens another avenue for revenue but an additional platform to showcase our established brands and IP. Their well-established distribution network is the first step and an important piece in the Company’s strategic expansion plan.”

New Leaf Ventures is a licensed producer and processor of ultra-premium cannabis. The company’s flagship enterprise is New Leaf USA and its subsidiaries.

Shares in New Leaf Ventures (NLV) opened trading at C$0.27.


More From The Market Online

Odd Burger to add 40 locations in Florida

Odd Burger (TSXV:ODD) will develop 40 new locations in Florida over the next eight years, with its sights set on further U.S. expansion.

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.